Trauma clinical trials at UCSF

2 in progress, 1 open to eligible people

Showing trials for

  • Cold Stored Platelet in Hemorrhagic Shock

    open to eligible people ages 15-90

    The Cold Stored Platelet Early Intervention in Hemorrhagic Shock (CriSP-HS) trial is a proposed 3 year, open label, multi-center, randomized trial designed to determine the feasibility, efficacy, and safety of urgent release cold stored platelets (CSP) in patients in hemorrhagic shock. Patients will be randomized to receive either standard care or early infusion of urgent release cold stored platelets (CSP). The proposed pilot study will utilize 5 level-1 trauma centers from within the LITES network and will enroll approximately 200 patients. The primary outcome for the pilot trial is feasibility, with principal secondary clinical outcome of 24 hour mortality.

    San Francisco, California and other locations

  • Quantra QStat in Trauma and Liver Transplant

    Sorry, accepting new patients by invitation only

    This is a multi-center prospective, observational study of the Quantra System with the QStat Cartridge in trauma patients and patients undergoing liver transplant.

    San Francisco, California and other locations

Our lead scientists for Trauma research studies include .

Last updated: